Ignite Creation Date:
2024-05-06 @ 8:42 AM
Last Modification Date:
2024-10-26 @ 12:04 PM
Study NCT ID:
NCT02801097
Status:
TERMINATED
Last Update Posted:
2022-05-17
First Post:
2016-06-10
Brief Title:
RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer PAYLOAD
Sponsor:
EpicentRx Inc
Organization:
EpicentRx Inc
Organization Data
Organization:
EpicentRx Inc
Class:
INDUSTRY
Study ID:
RRx001-16-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EpicentRx Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None